Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Mary J. EATON"'
Publikováno v:
Neurology Research International, Vol 2011 (2011)
Transplant of cells which make biologic agents that can modulate the sensory and motor responses after spinal cord injury (SCI) would be useful to treat pain and paralysis. To address this need for clinically useful human cells, a unique neuronal cel
Externí odkaz:
https://doaj.org/article/e8ec0d9664f8427ebc9b53ea240774a0
Publikováno v:
Pain Research and Treatment, Vol 2012 (2012)
Pain Research and Treatment
Pain Research and Treatment
Treatment of sensory neuropathies, whether inherited or caused by trauma, the progress of diabetes, or other disease states, are among the most difficult problems in modern clinical practice. Cell therapy to release antinociceptive agents near the in
Publikováno v:
Neurology Research International, Vol 2011 (2011)
Neurology Research International
Neurology Research International
Transplant of cells which make biologic agents that can modulate the sensory and motor responses after spinal cord injury (SCI) would be useful to treat pain and paralysis. To address this need for clinically useful human cells, a unique neuronal cel
Autor:
Mary J. Eaton
Publikováno v:
Expert Opinion on Biological Therapy. 4:1861-1869
Cell therapy to treat neuropathic pain after spinal cord injury (SCI) is in its infancy. However, the development of cellular strategies that would replace or be used as an adjunct to existing pharmacological treatments for neuropathic pain have prog
Publikováno v:
Brain Research. 913:35-46
Spinal hemisection injury at T13 results in development of permanent mechanical allodynia and thermal hyperalgesia due to interruption and subsequent loss of descending inhibitory modulators such as serotonin (5-HT) and its transporter (5-HT T ). We
Publikováno v:
Journal of Neurotrauma. 18:471-477
Pharmacological treatment for neuropathic pain, although often effective for brief periods, can result in intractable persistent pain with certain patients. Cell therapy for neuropathic pain is a newly developing technology useful for an examination
Autor:
Mary J. Eaton
Publikováno v:
Journal of the Peripheral Nervous System. 5:59-74
Pharmacologic treatment for the symptoms of painful neuropathy has been problematic, because there has been limited understanding of the underlying etiologies and systemic levels that an effective dose can have on multiple side effects. The use of mo
Autor:
Miguel Martinez, Shaffiat Karmally, Paloma Cejas, Martin Oudega, Mary J. Eaton, M. McKillop, J. McKillop, J A Plunkett
Publikováno v:
Pain. 86:195-210
Chronic delivery of anti-nociceptive molecules by means of cell grafts near the pain processing centers of the spinal cord is a newly developing technique for the treatment of neuropathic pain. The rat neuronal cell line, RN33B, derived from E13 rat
Autor:
Jacqueline Sagen, T Lopez, Beata R. Frydel, Jian Huang, Mary J. Eaton, John McKillop, Xing T. Nie
Publikováno v:
Journal of Cellular Biochemistry. 79:38-57
Adrenal chromaffin cells have been successfully used to attenuate chronic pain when transplanted near the spinal cord, but primary cells are neither homogeneous nor practical for routine use in human therapy. Conditional immortalization with the temp
Autor:
Paloma Cejas, Scott R. Whittemore, J A Plunkett, Miguel Martinez, Shaffiat Karmally, Mary J. Eaton, T Lopez
Publikováno v:
Cell Transplantation, Vol 8 (1999)
The use of cell lines utilized as biologic “minipumps” to provide antinociceptive molecules, such as GABA, in animal models of pain is a newly developing area in transplantation biology. The neuronal cell line, RN33B, derived from E13 brain stem